Managing Insomnia: Optimal Treatment Goals to Improve Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2019 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2020 to January 1, 2021

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Eisai

Description:
Insomnia is a sleep disorder which makes it difficult to fall or stay asleep, even when a person is tired and has the opportunity to do so. Insomnia is the second highest health related complaint worldwide as lack of adequate sleep saps energy levels, affects mood, and causes stress with overall health, work performance, and quality of life. The dangers of insomnia affect more than a person’s mood and if not treated properly can lead to adverse effects such as anxiety, depression, irritability, concentration and memory problems, reduced reaction time, poor immune system function, hypertension, and type II diabetes. Many adults experience acute insomnia at some point in their life, which can last for days or weeks and is usually the result of stress or a traumatic event.

Upon completion of this activity, participants will be able to:

  • Analyze the clinical data for the safety and efficacy profiles in emerging pharmacologic therapies

  • Discuss the current guideline recommendations for diagnosis and treatment of insomnia

  • Assess the current pharmacotherapy options for patients with insomnia and how they can impact the treatment goals

  • Describe the impact of adherence and how untreated insomnia can affect overall patient outcomes

  • Examine how a multidisciplinary team model can utilize a sleep management plan to effective change a patient’s sleep-wake cycle through proper screening and treatment
     

Faculty: Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Director, Jefferson Sleep Disorders Center
Thomas Jefferson University

Disclosure:

Dr. Doghramji serves as a consultant for Eisai, Jazz, Harmony, Merck, and Pfizer. He has received grant/research support from Eisai, Harmony, Inspire, and Jazz. He owns stock in Merck. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Eisai

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue